We provide integrated R&D validation and strategic financial advisory for the global biotechnology and supplement sectors. We don’t just manage your burn—we optimize your Return on Science (RoS).
Bridging the gap between the Bench & the Balance Sheet.
The Scientific Gap
Traditional R&D is slow and expensive. Without rapid, mechanistic proof-of-concept, high-potential molecules stall in the pipeline.
The Investment Gap
Asset managers and funders often view R&D as a “black box.” Without institutional-grade financial modeling, technical milestones lack the transparency required for global capital.
Elegan C bridges that gap
We are a dual-engine consultancy that provides the mechanistic data necessary for validation and the financial strategy required for scale.